These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25577552)

  • 1. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
    Kang HJ; Kim IH; Sung CO; Shim JH; Yu E
    Virchows Arch; 2015 Apr; 466(4):403-13. PubMed ID: 25577552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M
    Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
    Hyuga S; Wada H; Eguchi H; Otsuru T; Iwgami Y; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Int J Oncol; 2017 Oct; 51(4):1179-1190. PubMed ID: 28849188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.
    Aomatsu N; Yashiro M; Kashiwagi S; Kawajiri H; Takashima T; Ohsawa M; Wakasa K; Hirakawa K
    BMC Cancer; 2014 Jun; 14():400. PubMed ID: 24893880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
    Kim JY; Lee SH; An S; Kim SJ; Sung YN; Song KB; Hwang DW; Kim SC; Hong SM
    Virchows Arch; 2018 May; 472(5):739-748. PubMed ID: 29666945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
    Choi SW; Kim JY; Park JY; Cha IH; Kim J; Lee S
    Hum Pathol; 2008 Sep; 39(9):1317-22. PubMed ID: 18440050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
    Hua KT; Liu YF; Hsu CL; Cheng TY; Yang CY; Chang JS; Lee WJ; Hsiao M; Juan HF; Chien MH; Yang SF
    Sci Rep; 2017 Jun; 7(1):4466. PubMed ID: 28667334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival.
    Williams E; Martin S; Moss R; Durrant L; Deen S
    Virchows Arch; 2012 Jul; 461(1):33-9. PubMed ID: 22699808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
    J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
    Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
    Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
    Finkelmeier F; Canli Ö; Peiffer KH; Walter D; Tal A; Koch C; Pession U; Vermehren J; Trojan J; Zeuzem S; Piiper A; Greten FR; Grammatikos G; Waidmann O
    PLoS One; 2018; 13(7):e0200855. PubMed ID: 30011326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.
    Kim JY; Shin HJ; Kim TH; Cho KH; Shin KH; Kim BK; Roh JW; Lee S; Park SY; Hwang YJ; Han IO
    J Cancer Res Clin Oncol; 2006 May; 132(5):302-8. PubMed ID: 16416108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA9 expression as a prognostic factor in renal clear cell carcinoma.
    Soyupak B; Erdoğan S; Ergin M; Seydaoğlu G; Kuzgunbay B; Tansuğ Z
    Urol Int; 2005; 74(1):68-73. PubMed ID: 15711113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
    Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
    Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL
    J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
    Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.